Abstract
Endocrine resistance is a major barrier in estrogen receptor–positive (ER+) breast cancer, yet post‑transcriptional contributions remain unclear. Stress granules (SGs) are dynamic ribonucleoprotein assemblies that regulate mRNA fate during stress and support cancer cell survival, but their role in endocrine resistance is not well defined. Building on evidence that cytoplasmic androgen receptor (AR) interacts with the SG protein G3BP1, we hypothesized that AR–SG coupling rewires translational control to promote survival. We identify cytoplasmic AR as a regulator of SG function that drives adaptive post‑transcriptional reprogramming in aromatase inhibitor (AI)–resistant models. Using 2D/3D systems, imaging, RNA immunoprecipitation sequencing, we show that androgens induce AR–G3BP1 SG complexes that selectively sequester stress‑response transcripts, altering translation. In resistant cells, AR‑dependent SG remodeling reduced translation of key targets including PARP1 and EGR1. Disrupting SG assembly with epigallocatechin gallate selectively impaired resistant cell viability, reversible with androgen deprivation. Analysis of primary tumors (n=57) showed enrichment of cytoplasmic AR–SG complexes in aggressive subtypes. These findings define an AR–G3BP1 condensate axis linking steroid signaling to RNA regulation and highlight SG dynamics as a therapeutic vulnerability.